Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)
Recruiting · NCT06189209 · Registry updated 2025-12-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC) | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Recruiting | Phase 2 | 2025-12-02 | NCT06189209 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Incozen Therapeutics Pvt Ltd | 1 |
| Rhizen Pharmaceuticals SA | 1 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| HCG City Cancer Center | Vijayawada | India | 1 |
| Health Point Hospital | Kolkata | India | 2 |
| Meenakshi Mission Hospital & Research Center | Madurai | India | 1 |
| Mumbai Oncocare Centre | Mumbai | India | 1 |
| Narayana Hrudayala Majumdar Shaw Hospital | Bangalore | India | 1 |
| Nizams Institute of Medical Science | Hyderabad | India | 2 |
| Nobel Hospital | Pune | India | 1 |
| Sahyadri Super Speciality Hospital | Pune | India | 17 |
| Tata Memorial Centre | Mumbai | India | 13 |